Our roundup is up! Amazon adds Amazon Connect Health agentic AI for provider workflows to their roster. Amazon’s multiplicity of niches in healthcare adds a new solution, this t ...

Wasn’t this GLP-1 compounding tussle supposed to be over by now? FDA has sent warning letters to 30 telehealth companies warning them about their continued sale of compounded GLP-1 drugs. The warning ...

In yesterday’s update to pending record layoffs at Oracle, affecting Oracle Health, new reporting mentioned the breakdown of Oracle’s expansion agreement with OpenAI in building out a leased data ...

We now know another piece of the puzzle on why so many Oracle Health top executives have departed. Bloomberg’s Brody Ford has followed up his earlier report on five departures of key executives at ...

Oracle had good news yesterday. Its Q3 2026 closed with strong earnings per share ($1.79 adjusted EPS versus expected $1.70), GAAP adjusted EPS at $1.27, and revenue topping $17.19 billion versus the ...

Grow Therapy’s $150 million Series D brings their total funding to $328 million and their valuation to $3 billion. Their combination of in-person and telehealth visits with clinicians and ...

The long Masimo drama has a Hollywood Ending, at least for shareholders. The sale announced on Tuesday 17 February is a rich one–$180 per share, cash. (Masimo was trading in the ~$130/share range last ...

Rock Health’s 2025 digital health roundup, published in January, was upbeat–as usual, and in no way Hemingwayan. Their calculation of US digital health fundings was up 35% versus 2024, rising to $14.2 ...

Cue the swelling music from Max Steiner, or a modern score from George Antheil. Joe Kiani, the former CEO/founder of Masimo, has moved on from his booting (with extreme prejudice, one can say) from ...

Legacy telehealth continues to struggle to find its place–and profitability. Amwell expects to turn the positive operating cash flow corner in 2026…maybe. American Well closed out its 2025 with total ...